Byers Auditorium
Register for Zoom
The Future of HIV Prevention
Monica Gandhi, MD, MPH
Oral pre-exposure prophylaxis (PrEP) was approved in 2012 and we now have new options for HIV prevention, both approved and on the horizon. With these tools and HIV treatment we could end the HIV epidemic but we are in a challenging time where this goal is severely threatened. Dr. Gandhi will discuss available and future HIV prevention options and what’s at stake for not investing in advancing our HIV prevention goals worldwide.
Monica Gandhi, MD, MPH, is a Professor of Medicine and Associate Chief in the Division of HIV, Infectious Diseases, and Global Medicine at the University of California, San Francisco (UCSF). She is also the Director of the UCSF Center for AIDS Research (CFAR) and the Medical Director of the HIV Clinic (“Ward 86”) at San Francisco General Hospital. She serves as the Associate Program Director of the ID fellowship at UCSF. Her research focuses on HIV treatment and prevention optimization, HIV and women, adherence measurement in HIV and TB, adherence interventions, and optimizing the use of long-acting antiretroviral therapy (ART).
UCSF welcomes all participants to our events. If you need a reasonable accommodation to participate in this event because of a disability, please contact Pilar Deer at pilar.deer@ucsf.edu as soon as possible.